- Home
- FSBW vs RNAC Comparison
FSBW vs RNAC Comparison
Compare FSBW & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBW
- RNAC
- Stock Information
- Founded
- FSBW 1936
- RNAC 2007
- Country
- FSBW United States
- RNAC United States
- Employees
- FSBW N/A
- RNAC N/A
- Industry
- FSBW Banks
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- FSBW Finance
- RNAC Health Care
- Exchange
- FSBW Nasdaq
- RNAC Nasdaq
- Market Cap
- FSBW 324.8M
- RNAC 276.3M
- IPO Year
- FSBW 2012
- RNAC 2016
- Fundamental
- Price
- FSBW $42.71
- RNAC $10.05
- Analyst Decision
- FSBW Hold
- RNAC Strong Buy
- Analyst Count
- FSBW 1
- RNAC 4
- Target Price
- FSBW $44.00
- RNAC $40.00
- AVG Volume (30 Days)
- FSBW 17.6K
- RNAC 46.5K
- Earning Date
- FSBW 10-21-2025
- RNAC 08-07-2025
- Dividend Yield
- FSBW 2.62%
- RNAC N/A
- EPS Growth
- FSBW N/A
- RNAC N/A
- EPS
- FSBW 4.15
- RNAC N/A
- Revenue
- FSBW $139,676,000.00
- RNAC $1,026,000.00
- Revenue This Year
- FSBW $9.62
- RNAC N/A
- Revenue Next Year
- FSBW $5.35
- RNAC N/A
- P/E Ratio
- FSBW $10.31
- RNAC N/A
- Revenue Growth
- FSBW 0.61
- RNAC N/A
- 52 Week Low
- FSBW $34.61
- RNAC $8.46
- 52 Week High
- FSBW $49.15
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- FSBW 61.80
- RNAC 34.71
- Support Level
- FSBW $41.40
- RNAC $10.50
- Resistance Level
- FSBW $42.89
- RNAC $11.80
- Average True Range (ATR)
- FSBW 1.14
- RNAC 0.56
- MACD
- FSBW 0.32
- RNAC -0.11
- Stochastic Oscillator
- FSBW 95.42
- RNAC 0.45
About FSBW FS Bancorp Inc.
FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.